CanSino Biologics Inc.
CanSino Biologics Inc. (CASBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CASBF · as of Jun 8, 2026
Key Statistics
Explore CanSino Biologics Inc. Data
casbf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
casbf competitorsCASBF
APNHY
ARSUF
CHSYF
CURLF
DMPHFStock Performance
Full HistoryAbout CanSino Biologics Inc.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant no…
what is cansino biologics inc. · casbf stock overview · cansino biologics inc. company profile · who is cansino biologics inc. ceo · casbf OTC · cansino biologics inc. headquarters · cansino biologics inc. business segments
About Stock Overview & Key Data
CanSino Biologics Inc. (CASBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 2, 2020. As of the latest trading session, CASBF stock price is $3.10, with a market capitalization of $1.1B. The stock has returned -3.13% over the past 12 months and -34.60% year-to-date.
In fiscal year 2025, CanSino Biologics Inc. reported revenue of $1.0B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CanSino Biologics Inc. (CASBF) stock price is $3.10. The stock is traded on OTC under the ticker symbol CASBF. The 52-week range is $3.00 – $6.99.